chr6-64813571-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001142800.2(EYS):āc.3250A>Cā(p.Thr1084Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000809 in 1,544,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001142800.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.3250A>C | p.Thr1084Pro | missense_variant | 22/43 | ENST00000503581.6 | NP_001136272.1 | |
EYS | NM_001292009.2 | c.3250A>C | p.Thr1084Pro | missense_variant | 22/44 | NP_001278938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.3250A>C | p.Thr1084Pro | missense_variant | 22/43 | 5 | NM_001142800.2 | ENSP00000424243 | A2 | |
EYS | ENST00000370621.7 | c.3250A>C | p.Thr1084Pro | missense_variant | 22/44 | 1 | ENSP00000359655 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000795 AC: 12AN: 151038Hom.: 0 AF XY: 0.0000499 AC XY: 4AN XY: 80224
GnomAD4 exome AF: 0.0000424 AC: 59AN: 1392598Hom.: 0 Cov.: 29 AF XY: 0.0000320 AC XY: 22AN XY: 686916
GnomAD4 genome AF: 0.000434 AC: 66AN: 152050Hom.: 0 Cov.: 32 AF XY: 0.000337 AC XY: 25AN XY: 74278
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 08, 2019 | This variant is associated with the following publications: (PMID: 26667666, 29550188, 25097241) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 20, 2015 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2022 | This sequence change replaces threonine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 1084 of the EYS protein (p.Thr1084Pro). This variant is present in population databases (rs778646190, gnomAD 0.1%). This missense change has been observed in individual(s) with retinal disease. However, this variant has frequently been identified on the same chromosome as other EYS variants, making its clinical significance uncertain (PMID: 25097241, 26667666, 29550188). ClinVar contains an entry for this variant (Variation ID: 195666). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The proline amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Retinitis pigmentosa 25 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Mar 06, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Autosomal recessive retinitis pigmentosa Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Aug 31, 2020 | - - |
EYS-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 16, 2024 | The EYS c.3250A>C variant is predicted to result in the amino acid substitution p.Thr1084Pro. This variant has been reported in individuals with retinitis pigmentosa; however, in several of these cases it was determined to be on the same allele (in cis) with the pathogenic variant c.3443+1G>T as well as the uncertain missense variant c.4402G>C (p.Asp1468His) (Wang et al. 2014. PubMed ID: 25097241; Ge et al. 2015. PubMed ID: 26667666; Sengillo et al. 2018. PubMed ID: 29550188). This variant is reported in 0.15% of alleles in individuals of African descent in gnomAD. Although we suspect that this variant may be benign by itself, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Aug 08, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at